Qube Research & Technologies Ltd - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$210,719
-68.1%
16,777
-58.1%
0.00%
-66.7%
Q1 2023$660,101
+3.7%
40,079
-5.9%
0.00%0.0%
Q4 2022$636,474
-36.1%
42,602
-28.4%
0.00%
-57.1%
Q2 2022$996,00059,4840.01%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,139,380$73,958,0008.86%
Darwin Global Management, Ltd. 782,471$27,050,0005.30%
EcoR1 Capital, LLC 3,429,363$118,553,0005.26%
Foresite Capital Management V, LLC 400,000$13,828,0004.06%
Grace Capital 183,112$6,330,0004.03%
BVF INC/IL 2,873,147$99,325,0003.72%
Casdin Capital, LLC 3,375,058$116,676,0003.48%
Fernwood Investment Management, LLC 185,063$6,398,0002.35%
Alphabet Inc. 1,568,486$54,222,0002.19%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$964,675,0001.67%
View complete list of RELAY THERAPEUTICS INC shareholders